Tech Company Financing Transactions
Neosil Funding Round
Neosil closed a $32 million Series A financing round on 11/8/2004. Investors included MPM Capital and Burrill & Company.
Transaction Overview
Company Name
Announced On
11/8/2004
Transaction Type
Venture Equity
Amount
$32,000,000
Round
Series A
Investors
MPM Capital (Lead Investor) (Nicholas Simon)
Burrill & Company (Ann Hanham)
Proceeds Purpose
The financing will enable Neosil to complete preclinical work on existing topical anti-bacterial and anti-fungal programs and to advance these programs into clinical trials. This financing will also allow the Company to identify and in-license complementary products targeting unmet needs in dermatology.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
5980 Horton St 525
Emeryville, CA 94608
USA
Emeryville, CA 94608
USA
Phone
Website
Email Address
Overview
Neosil is a privately-held dermatology-focused specialty pharmaceutical company with several products in pre-clinical development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eugene Bauer
Chief Operating Officer
Clarence Dellio
Browse more venture capital transactions:
Prev: 11/5/2004: Ascenta Therapeutics venture capital transaction
Next: 11/8/2004: BoardVantage venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record tech company VC transactions. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs